Skip to content

Mass General at #AANS2019

In This Article

  • At #AANS2019, neurosurgical clinicians and researchers from Massachusetts General Hospital present their world-class research and innovative treatment approaches
  • This article is a preview of some can't-miss sessions and presentations
  • Physicians and researchers will present on specialties including gliomas, the latest in clinical trials, brain trauma and pituitary

The 2019 AANS Annual Scientific Meeting is a global exchange for neurosurgical scientists and clinicians. Specialists from Mass General Neuroscience will present and debate leading research and innovative treatment approaches in neurosurgical care. 

Here are five highlights from this year’s meeting:

Practical Clinic: Bedside Biostatistics: How to Find and Use Evidence to Take Care of Patients
Saturday, April 13: 8:00 am–5:00 pm
Fred G. Barker II, MD

Breakfast Seminar: Adult Low-grade Gliomas
Monday, April 15: 7:00–9:00 am
Daniel Cahill, MD, PhD

Neurosurgery in Press – Latest Results in Clinical Trials in Neurosurgery and Allied Fields
Monday, April 15: 1:40–2:30 pm
Fred G. Barker II, MD; Daniel Cahill, MD, PhD

Breakfast Seminar: Return-to-play After Sports Injury II: Concussion
Tuesday, April 16: 7:00-9:00 am
Ann-Christine Duhaime, MD

Breakfast Seminar: Pituitary Tumors
Tuesday, April 16: 7:00-9:00 am
Pamela S. Jones, MD

Register now for the 2019 AANS Scientific Meeting

Learn about Mass General Neuroscience

Related topics


Mass General has developed a genotype-targeted therapy for glioma, designed to be given at the tumor site during surgery, and an accompanying rapid diagnostic.


Researchers from the Department of Neurosurgery at Massachusetts General Hospital discuss their collaborative work in clinical and translational research.